Skip to content

Efficacy of oliceridine on quality of patients early recovery in video-assisted thoracoscopic surgery

Efficacy of oliceridine on quality of patients early recovery in video-assisted thoracoscopic surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096716
Enrollment
Unknown
Registered
2025-02-05
Start date
2025-02-17
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative analgesia

Interventions

Oliceridine group:Patients in the oliceriding group will receive oliceridine 1.5mg analgesic treatment after operation oliceridine 0.5mg should be given for analgesic relief during PACU stay time
Morphine gruop:Patients in the morphine group will receive morphine 4mg analgesic treatment after operation morphine 1mg should be given for analgesic relief during PACU stay time

Sponsors

The Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who undergo elective thoracoscopic surgery; 2. Age 18-75 years old; 3. ASAI.-III; 4. BMI 18.5-30kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Preoperative respiratory failure; 2. Advanced tumors with extensive metastasis or need to receive other adjuvant therapy; 3. Suffering from respiratory sleep apnea syndrome; 4. Hepatic or renal insufficiency; 5. Long-term use of sleeping pills; 6. Long-term hormone therapy; 7. Suffering from mental illness; 8. Lactation; 9. Chronic pain before surgery; 10. Hypersensitivity to the investigational drugs.

Design outcomes

Primary

MeasureTime frame
Extubation time;

Secondary

MeasureTime frame
Modified alertness-sedation score during the PACU stay;NRS score;The numbers of analgesic remedies during PACU stay;PACU stay time;Postoperative adverse reactions;QoR-15 of 24 hours after surgery;Time to first ambulation (hours from surgery end);Time to first oral intake (hours from surgery end);Adverse reactions during PACU stay;

Countries

China

Contacts

Public ContactChen Ying

The Second Affiliated Hospital of Kunming Medical University

15559672131@163.com+86 158 7796 7204

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026